Androgenetic Alopecia Treatment Market Synopsis:
Androgenetic Alopecia Treatment Market Size Was Valued at USD 8.79 Billion in 2023 and is Projected to Reach USD 19.41 Billion by 2032, Growing at a CAGR of 9.2 % From 2024-2032.
The Androgenetic Alopecia Treatment Market is focused on the diagnosis and management and cure or prevention of androgenetic alopecia – a genetic type of hair loss or baldness, including both male or female pattern baldness. It includes drugs and preparations for hair treatment and hair replacement; therapeutic hair restoration surgical operations; and numerous new treatments for fighting baldness or for stimulating hair re-growth or improving the condition of the scalp in general.
The Androgenetic Alopecia Treatment Market has shown development because of increased instances of the condition all over the world, particularly in the geriatric and midadult years. The major reason that is boosting the demand for this market is the rising population and more organs banks and a growing awareness of the people about the hair restoration therapies has ensured more people are coming forward for treatment for hair loss. The continuous research support is the development of better treatments and friendly way of handling the therapy through topical and oral products, low invasive techniques and lasers.
Rise in disposable income especially in the arising markets has also increased the purchase of premium hair care products and synergistic clinic. This, coupled with changing beauty standards because of social media pressure makes hair restoration a necessity for most people. Such health industry big guns of the biotechnology as well as the pharmaceutical industry carrying out the new research and development work are likely to introduce new treatment options themselves that will be safer and more effective.
.webp)
Androgenetic Alopecia Treatment Market Trend Analysis:
Personalized Treatments Driving Market Evolution
- The increasing utilization of client customized therapies is one of the rising trends that affects the outlook of the Androgenetic Alopecia Treatment Market. Soon, when genetic responsible for the phenotypes didn’t necessarily own by the people as their genotype connected with genomics, biotechnology and specializations in treatment planning start, patients get medical treatment regarding their genotype and healing pattern of alopecia. It enhances the quality of its treatments and the happiness level among the patients it attends to. However, in the recent past, products using the concept of artificial intelligence and digital platforms for diagnosing and monitoring hair loss, offering even real-time data with involvement of more personalized ways have also been introduced. Schemes like such are making the treatments cheaper and much more efficient thus ensuring that the market will always be on the rise one way the other
Expanding Markets in Emerging Economies
- The Androgenetic Alopecia Treatment Market is filled with a number of opportunities in the Asia-Pacific and the Latin American emerging countries. Several social factors like the growing population of middle-income people, increase in disposable income and rising awareness about hair restorative products in the market are helping companies. These governments are also pumping cash into efforts to improve the health care so that expensive therapies are attainable. In addition, competition from global and regional players into such markets has also made it possible to achieve optimum ‘Pricing’ and appropriately developed solutions that are appropriate to such markets. These elements essentially precondition emerging markets as the desired path of growth.
Androgenetic Alopecia Treatment Market Segment Analysis:
Androgenetic Alopecia Treatment Market is Segmented based on Disease Type, Treatment Type, Gender, and Region.
By Disease Type, the Androgenetic Alopecia segment is expected to dominate the market during the forecast period
- The androgenetic alopecia segment shall remain an ongoing leader in the market throughout the forecast timeline because this hair loss is possible in both males and females and has a clear reference to genetic factors well defined. This is a common ailment and makes up a very high percentage of all alopecia-related ailments Hence, there is enough market for effective treatments. Minoxidil is used in treating it topically, finasteride is administered orally while other complex operations such as PRP therapy are often used. Also, awareness camps and messages regarding early intervention by related healthcare organizations and pharmaceutical companies have expanded this segment. It took time for the use of new treatments like stem cell therapy and hair follicle cloning but these are likely to open up better chances of addressing the demands of the androgenetic alopecia patient segment to keep this segment dominant in the global market in the future
By Treatment Type, the pharmaceuticals segment is expected to held the largest share
- Due to the enhanced usage of the drugs like minoxidil and finasteride approved by Food and Drug Administration, the pharma segment is expected to lead the Androgenetic Alopecia Treatment Market. These drugs have been found to be effective in the treatment of androgenetic alopecia, convenient to administer and are non-prescription drugs. Such patients simply prefer to take tablets and capsules because such treatment is more mobile, less invasive, and less expensive than more elaborate types of surgery. It is also being helped by the progress made in the drugs delivery that include; topical sprays, slow release tagged formulations with improved user friendliness and earlier compliance thus improved sales. Furthermore, long-term continued and exclusive core R&D by innovative drug makers to refine contain, efficacy and outreach of therapeutic tablets and potions also bolsters this segment. Further awareness and availability of the products will make the pharmaceuticals segment to continue being the main force pushing the personal care appliances market.
Androgenetic Alopecia Treatment Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- The dominance is a result of several factors, for instance, there is improved health facilities infrastructure, enhanced disposable income, and well-enhanced beauty treatments. Higher life stress due to lifestyle changes, consecutive stressful conditions, and growing androgenetic alopecia in the aging population of the region have collectively created higher interest
- In effective hair-rebuilding solutions. America has played the most significant role in market expansion in North America thanks to modern treatments ranging from FDA-approved pharmaceuticals and the newest devices to PRP therapy. North American market is highly developed due to huge numbers of pharma and biotech firms investing more money in research and development. They have made organizations develop and come up with better products in the market such as better drug delivery systems and other therapeutic solutions such as stem cell therapy. Supportive insurance policies as well as the awareness created by social media have also played a role in the increased use of these treatments. Further, the consolidated efforts made in the North American region on innovative research and comparatively higher healthcare expenditure keep this region on the top of the global Androgenetic Alopecia Treatment Market.
Active Key Players in the Androgenetic Alopecia Treatment Market:
- Allergan (Ireland)
- Aclaris Therapeutics, Inc. (USA)
- Alpecin (Germany)
- Cipla Ltd. (India)
- Daiichi Sankyo Company, Limited (Japan)
- Dermira, Inc. (USA)
- Evolis Professional (Australia)
- Johnson & Johnson (USA)
- L’Oreal SA (France)
- Merck & Co., Inc. (USA)
- Pfizer Inc. (USA)
- RepliCel Life Sciences Inc. (Canada)
- Revivogen (USA)
- Shiseido Company, Limited (Japan)
- Sun Pharmaceutical Industries Ltd. (India), and Other Active Players
|
Androgenetic Alopecia Treatment Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 8.79 Billion |
|
Forecast Period 2024-32 CAGR: |
9.2 % |
Market Size in 2032: |
USD 19.41 Billion |
|
Segments Covered: |
By Disease Type |
|
|
|
By Treatment Type |
|
||
|
By Gender |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Androgenetic Alopecia Treatment Market by Disease Type
4.1 Androgenetic Alopecia Treatment Market Snapshot and Growth Engine
4.2 Androgenetic Alopecia Treatment Market Overview
4.3 Alopecia Areata
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Alopecia Areata: Geographic Segmentation Analysis
4.4 Cicatricial Alopecia
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Cicatricial Alopecia: Geographic Segmentation Analysis
4.5 Traction Alopecia
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Traction Alopecia: Geographic Segmentation Analysis
4.6 Alopecia Totalise
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Alopecia Totalise: Geographic Segmentation Analysis
4.7 Androgenetic Alopecia
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Androgenetic Alopecia: Geographic Segmentation Analysis
4.8 Alopecia Universalis OtherTreatment
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Alopecia Universalis OtherTreatment: Geographic Segmentation Analysis
Chapter 5: Androgenetic Alopecia Treatment Market by Gender
5.1 Androgenetic Alopecia Treatment Market Snapshot and Growth Engine
5.2 Androgenetic Alopecia Treatment Market Overview
5.3 Male
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Male: Geographic Segmentation Analysis
5.4 Female
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Female: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Androgenetic Alopecia Treatment Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ALLERGAN (IRELAND)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 ACLARIS THERAPEUTICS INC. (USA)
6.4 ALPECIN (GERMANY)CIPLA LTD. (INDIA)
6.5 DAIICHI SANKYO COMPANY
6.6 LIMITED (JAPAN)
6.7 DERMIRA INC. (USA)
6.8 EVOLIS PROFESSIONAL (AUSTRALIA)
6.9 JOHNSON & JOHNSON (USA)
6.10 L’OREAL SA (FRANCE)
6.11 MERCK & CO. INC. (USA.)
6.12 PFIZER INC. (USA)
6.13 REPLICEL LIFE SCIENCES INC. (CANADA)
6.14 REVIVOGEN (USA)SHISEIDO COMPANY
6.15 LIMITED (JAPAN)
6.16 SUN PHARMACEUTICAL INDUSTRIES LTD. (INDIA)
6.17 OTHER ACTIVE PLAYERS
Chapter 7: Global Androgenetic Alopecia Treatment Market By Region
7.1 Overview
7.2. North America Androgenetic Alopecia Treatment Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Disease Type
7.2.4.1 Alopecia Areata
7.2.4.2 Cicatricial Alopecia
7.2.4.3 Traction Alopecia
7.2.4.4 Alopecia Totalise
7.2.4.5 Androgenetic Alopecia
7.2.4.6 Alopecia Universalis OtherTreatment
7.2.5 Historic and Forecasted Market Size By Gender
7.2.5.1 Male
7.2.5.2 Female
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Androgenetic Alopecia Treatment Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Disease Type
7.3.4.1 Alopecia Areata
7.3.4.2 Cicatricial Alopecia
7.3.4.3 Traction Alopecia
7.3.4.4 Alopecia Totalise
7.3.4.5 Androgenetic Alopecia
7.3.4.6 Alopecia Universalis OtherTreatment
7.3.5 Historic and Forecasted Market Size By Gender
7.3.5.1 Male
7.3.5.2 Female
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Androgenetic Alopecia Treatment Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Disease Type
7.4.4.1 Alopecia Areata
7.4.4.2 Cicatricial Alopecia
7.4.4.3 Traction Alopecia
7.4.4.4 Alopecia Totalise
7.4.4.5 Androgenetic Alopecia
7.4.4.6 Alopecia Universalis OtherTreatment
7.4.5 Historic and Forecasted Market Size By Gender
7.4.5.1 Male
7.4.5.2 Female
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Androgenetic Alopecia Treatment Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Disease Type
7.5.4.1 Alopecia Areata
7.5.4.2 Cicatricial Alopecia
7.5.4.3 Traction Alopecia
7.5.4.4 Alopecia Totalise
7.5.4.5 Androgenetic Alopecia
7.5.4.6 Alopecia Universalis OtherTreatment
7.5.5 Historic and Forecasted Market Size By Gender
7.5.5.1 Male
7.5.5.2 Female
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Androgenetic Alopecia Treatment Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Disease Type
7.6.4.1 Alopecia Areata
7.6.4.2 Cicatricial Alopecia
7.6.4.3 Traction Alopecia
7.6.4.4 Alopecia Totalise
7.6.4.5 Androgenetic Alopecia
7.6.4.6 Alopecia Universalis OtherTreatment
7.6.5 Historic and Forecasted Market Size By Gender
7.6.5.1 Male
7.6.5.2 Female
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Androgenetic Alopecia Treatment Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Disease Type
7.7.4.1 Alopecia Areata
7.7.4.2 Cicatricial Alopecia
7.7.4.3 Traction Alopecia
7.7.4.4 Alopecia Totalise
7.7.4.5 Androgenetic Alopecia
7.7.4.6 Alopecia Universalis OtherTreatment
7.7.5 Historic and Forecasted Market Size By Gender
7.7.5.1 Male
7.7.5.2 Female
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
|
Androgenetic Alopecia Treatment Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 8.79 Billion |
|
Forecast Period 2024-32 CAGR: |
9.2 % |
Market Size in 2032: |
USD 19.41 Billion |
|
Segments Covered: |
By Disease Type |
|
|
|
By Treatment Type |
|
||
|
By Gender |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
